Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

miDiagnostics HSV-1&2 CSF Test

K-Number: K250050 · 2025-09-30

Decision Date2025-09-30
Product CodePGH
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

miDiagnostics HSV-1&2 CSF Test is the device name listed in this FDA 510(k) record. The listed applicant is Midiagnostics NV. It received FDA 510(k) clearance on 2025-09-30 under 510(k) number K250050. The device is classified under product code PGH. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the miDiagnostics HSV-1&2 CSF Test?

miDiagnostics HSV-1&2 CSF Test is a medical device that received FDA 510(k) clearance on 2025-09-30. The listed applicant is Midiagnostics NV. The 510(k) number is K250050.

When did miDiagnostics HSV-1&2 CSF Test receive FDA 510(k) clearance?

miDiagnostics HSV-1&2 CSF Test received FDA 510(k) clearance on 2025-09-30, under 510(k) number K250050.

Who is the listed applicant for miDiagnostics HSV-1&2 CSF Test?

The FDA 510(k) record lists Midiagnostics NV as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for miDiagnostics HSV-1&2 CSF Test?

The FDA product code for miDiagnostics HSV-1&2 CSF Test is PGH.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.